Active components alignment of Gegenqinlian decoction protects ulcerative colitis by attenuating inflammatory and oxidative stress

Journal of Ethnopharmacology

Volumn 162, Issue , 2015, Pages 253-260

  Xu, Bei Lei ^a   Zhang, Gui Jun ^b   Ji, Yu Bin ^a  

^a HARBIN UNIVERSITY OF COMMERCE   (China)

^b BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Active components alignment of Gegenqinlian Decoction (ACAG); B Semi quantitative RT PCR; ELISA; Immuno histochemistry; Nuclear factor kappa; TNBS induced colitis

Indexed keywords

ALCOHOL; CHINESE DRUG; CYCLOOXYGENASE 2; FORMALDEHYDE; GEGENQINLIAN DECOCTION; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 2; MALONALDEHYDE; MESSENGER RNA; SUPEROXIDE DISMUTASE; SYNAPTOTAGMIN I; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TRINITROBENZENESULFONIC ACID; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; GEGENQINLIAN; HERBACEOUS AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLON MUCOSA; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ULCERATIVE COLITIS; ANIMAL; CHEMICALLY INDUCED; CHEMISTRY; COLITIS, ULCERATIVE; DRUG EFFECTS; GERMFREE ANIMAL; METABOLISM; RANDOMIZATION; SPRAGUE DAWLEY RAT;

RATTUS;

ANIMALS; COLITIS, ULCERATIVE; DRUGS, CHINESE HERBAL; INFLAMMATION; MALE; MALONDIALDEHYDE; NITRIC OXIDE SYNTHASE TYPE II; OXIDATIVE STRESS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; SPECIFIC PATHOGEN-FREE ORGANISMS; SUPEROXIDE DISMUTASE; TRINITROBENZENESULFONIC ACID;

EID: 84921626535     PISSN: 03788741     EISSN: 18727573     Source Type: Journal    
DOI: 10.1016/j.jep.2014.12.042     Document Type: Article

References (35)

1. V. Andersen, J. Christensen, A. Ernst, B.A. Jacobsen, A. Tjønneland, H.B. Krarup, and U. Vogel Polymorphisms in NF-κB, PXR, LXR, PPARγ and risk of inflammatory bowel disease World of Journal Gastroenterology 17 2011 197 206
2. I. Atreya, R. Atreya, and M.F. Neurath NF-kappaB in inflammatory bowel disease Journal of Internal Medicine 263 2008 591 596
3. C. Benard, A. Cultrone, C. Michel, C. Rosales, J.P. Segain, M. Lahaye, J.P. Galmiche, C. Cherbut, and H.M. Blottière Degraded carrageenan causing colitis in rats induces TNF secretion and ICAM-1 upregulation in monocytes through NF-kB activation PLoS One 5 2010 e8666
4. D. Bouzid, B. Gargouri, R.B. Mansour, A. Amouri, N. Tahri, S. Lassoued, and H. Masmoudi Oxidative stress markers in intestinal mucosa of Tunisian inflammatory bowel disease patients Saudi Journal of Gastroenterology 19 2013 131 135
5. M.M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Analytical Biochemistry 72 1976 248 254
6. S.X. Dai, Y. Zou, Y.L. Feng, H.B. Liu, and X.B. Zheng Baicalin down- regulates the expression of macrophage migration inhibitory factor (MIF) effectively for rats with ulcerative colitis Phytotherapy Research 26 2012 498 504
7. W. Dou, J. Zhang, A. Sun, E. Zhang, L. Ding, S. Mukherjee, X. Wei, G. Chou, Z.T. Wang, and S. Mani Protective effect of naringenin against experimental colitis via suppression of Tolllike receptor 4/NF-κB signaling British Journal of Nutrition 110 2013 599 608
8. R.C. Dutra, R.F. Claudino, A.F. Bento, R. Marcon, E.C Schmidt, Z.L. Bouzon, L.F. Pianowski, and J.B. Calixto Preventive and therapeutic euphol treatment attenuates experimental colitis in mice PLoS One 6 2011 e27122
9. L. Guo, C. Ye, X. Hao, R. Zheng, R. Ju, D. Wu, L. Luo, C. Wang, J. Li, L. Zhu, and D. Zhang Carboxyamidotriazole ameliorates experimental colitis by inhibition of cytokine production, nuclear Factor-κB activation, and colonic fibrosis Journal of Pharmacology and Experimental Therapeutics 342 2012 356 365
10. X.H. Han, J. Zhong, J.Y. Guo, R. Shi, X.H. Wang, C.H. Wang, K. Wang, G.L. Du, Y.H. Shen, and Y.M. Ma Relationships between pharmacokinetics and efficacy of Xie-xin decoction in rats with experimental ulcerative colitis Journal of Ethnopharmacology 148 2013 182 189
11. E.H. Joh, and D.H. Kim Lancemaside A inhibits lipopolysaccharide- induced inflammation by targeting LPS/TLR4 complex Journal of Cellular Biochemistry 111 2010 865 871
12. L. Koetzner, G. Grover, J. Boulet, and H.I. Jacoby Plant-derived polysaccharide supplements inhibit dextran sulfate sodium-induced colitis in the rat Digestive Diseases and Sciences 55 2009 1278 1285
13. T. Kudo, S. Okamura, Y. Zhang, T. Masuo, and M. Mori Topical application of glycyrrhizin preparation ameliorates experimentally induced colitis in rats World Journal of Gastroenterology 17 2011 2223 2228
14. H.M. Li, Y.Y. Wang, H.D. Wang, W.J. Cao, X.H. Yu, D.X. Lu, R.B. Qi, C.F. Hu, and Y.X. Yan Berberine protects against lipopolysaccharide-induced intestinal injury in mice via alpha 2 adrenoceptor-independent mechanisms Acta Pharmacologica Sinica 32 2011 1364 1372
15. R. Li, L. Xu, T. Liang, Y. Li, S. Zhang, and X. Duan Puerarin mediates hepatoprotection against CCl4-induced hepatic fibrosis rats through attenuation of inflammation response and amelioration of metabolic function Food and Chemical Toxicology 52 2013 69 75
16. B.G. Liu, X.M. Jia, Y.Y. Cao, S.H. Chen, P.H Gao, Y. Wang, Y.Y. Jiang, and Y.B. Cao Changtai granule, a traditional Chinese drug, protects hapten-induced colitis by attenuating inflammatory and immune dysfunctions Journal of Ethnopharmacology 15 2008 1 8
17. L. Liu, Y.H. Li, Y.B. Niu, Y. Sun, Z.J. Guo, Q. Li, J. Feng, S.S. Cao, and Q.B. Mei An apple oligogalactan prevents against inflammation and carcinogenesis by targeting LPS/TLR4/NF-κB pathway in a mouse model of colitis-associated colon cancer Carcinogenesis 31 2010 1822 1832
18. L. Liu, S.F. Yuan, Y. Sun, Y. Long, Y.H. Li, Y.B. Niu, C. Li, H.Q. Gan, S.S. Cao, and Q.B. Mei The possible mechanisms of Fructus Mume pill in the treatment of colitis induced by 2,4,6-trinitrobenzene sulfonic acid in rats Journal of Ethnopharmacology 126 2009 557 564
19. E.O. Long ICAM-1: getting a grip on leukocyte adhesion Journal of Immunology 186 2011 5021 5023
20. M.N. Marwa, G.T. Mariane, I.E. Moushira, and E.K. Amani Anti-inflammatory and anti-oxidant activities of olmesartan medoxomil ameliorate experimental colitis in rats Toxicology and Applied Pharmacology 271 2013 106 113
21. M.M. Nagib, M.G. Tadros, M.I. ElSayed, and A.E. Khalifa Anti-inflammatory and anti-oxidant activities of olmesartan medoxomil ameliorate experimental colitis in rats Toxicology and Applied Pharmacology 271 2013 106 113
22. A. Oeckinghaus, M.S. Hayden, and S. Ghosh Crosstalk in NF-κB signaling pathways Nature Immunology 12 2011 695 708
23. K.M. Sakthivel, and C. Guruvayoorappan Amentoflavone inhibits iNOS, COX-2 expression and modulates cytokine profile, NF-κB signal transduction pathways in rats with ulcerative colitis International Immunopharmacology 17 2013 907 916
24. A.Y. Sklyarov, N.B. Panasyuk, and I.S. Fomenko Role of nitric oxide- synthase and cyclooxygenase/lipooxygenase systems in development of experimental ulcerative colitis Journal of Physiology and Pharmacology 62 2011 65 73
25. I. Siddique, and I. Khan Mechanism of regulation of Na-H exchanger in inflammatory bowel disease: role of TLR-4 signaling mechanism Digestive Diseases and Sciences 56 2011 1656 1662
26. K. Singh, R. Chaturvedi, D.P. Barry, L.A. Coburn, M. Asim, N.D. Lewis, M.B. Piazuelo, M.K. Washington, M.P. Vitek, and K.T. Wilson The apolipoprotein E-mimetic peptide COG112 inhibits NF-kappaB signaling, proinflammatory cytokine expression, and disease activity in murine models of colitis Journal of Biological Chemistry 286 2011 3839 3850
27. J.L. Wallace, P. Braquet, G.C. Ibbotson, W.K. MacNaugton, and G. Cirino Assessment of the role of platelet-activating factor in an animal model of inflammatory bowel disease Journal of Lipid Mediators 1 1989 13 23
28. L. Wang, G.B. Zhou, P. Liu, J.H. Song, Y. Liang, X.J. Yan, F. Xu, B.S. Wang, J.H. Mao, Z.X. Shen, S.J. Chen, and Z. Chen Dissection ofmechanisms of Chinesemedicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia Proceeding of the National Academy of Sciences of the United States of America 105 2008 4826 4831
29. R.J. Xavier, and D.K. Podolsky Unravelling the pathogenesis of inflammatory bowel disease Nature 448 2007 427 434
30. B.L. Xu, G.J. Zhang, X.W. Cui, and C.X. Wen Study on Pharmacodynamics of GQF Journal of LiaoNing University of TCM 13 2011 99 101
31. B.L. Xu, G.J. Zhang, X.W. Cui, C.X. Wen, C.S. Liu, and Y.N. Zhang Determination of biological titers of active components alignments in Gegen Qinlian Decoction on bacteriostasis China Journal of Traditional Chinese Medicine and Pharmacy 28 2013 230 233
32. L.Z. Yu, J.Y. Wu, J.B. Luo, X.G. Huang, H. Lin, and Y.L. Xing Experimental study on anti-diarrhae effect of Gegenqinlian Decoction and its compounds Chinese Traditional Patent Medicine 27 2005 300 304
33. M. Zhang, Y. Long, Y. Sun, Y. Wang, Q. Li, H. Wu, Z. Guo, Y. Li, Y. Niu, C. Li, L. Liu, and Q. Mei Evidence for the complementary and synergistic effects of the three-alkaloid combination regimen containing berberine, hypaconitine and skimmianine on the ulcerative colitis rats induced by trinitrobenzene-sulfonic acid European Journal of Pharmacology 651 2011 187 196
34. P. Zhang, J. Hou, D. Li, C. Zhang, and J. Liu Baicalin protects rat brain microvascular endothelial cells injured by oxygen-glucose deprivation via anti-inflammation Brain Research Bulletin 97 2013 8 15
35. H. Zhu, and Y.R. Li Oxidative stress and redox signaling mechanisms of inflammatory bowel disease: updated experimental and clinical evidence Experimental Biology Medicine (Maywood) 237 2012 474 480